James C. Lee

Holistic Medicine

493 7th Ave
Brooklyn, NY 11215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

Journal: Journal of Crohn's & colitis

Published: May 22, 2026

HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.

HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.

Journal: The lancet. Gastroenterology & hepatology

Published: February 20, 2026

REACH: C-cause.

REACH: C-cause.

Journal: Journal of Crohn's & colitis

Published: February 19, 2026

Vedolizumab treatment outcomes in early versus late Crohn's disease.

Vedolizumab treatment outcomes in early versus late Crohn's disease.

Journal: The lancet. Gastroenterology & hepatology

Published: November 19, 2025

Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.

Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.

Journal: Journal of Crohn's & colitis

Published: October 22, 2025

Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Journal: Nature

Published: September 16, 2025

The Role of ETS2 in Macrophage Inflammation.

The Role of ETS2 in Macrophage Inflammation.

Journal: DNA and cell biology

Published: April 14, 2025

Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?

Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?

Journal: Expert review of gastroenterology & hepatology

Published: March 20, 2025

Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease.

Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease.

Journal: United European gastroenterology journal

Published: February 02, 2025

Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial - Authors' reply.

Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial - Authors' reply.

Journal: The lancet. Gastroenterology & hepatology

Published: May 03, 2024

Vitamin D regulates microbiome-dependent cancer immunity.

Vitamin D regulates microbiome-dependent cancer immunity.

Journal: Science (New York, N.Y.)

Published: April 25, 2024

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.

Journal: The lancet. Gastroenterology & hepatology

Published: January 25, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026